Liven Pharma cuts quarterly loss by 76% to Rs7m

News Image

MG News | November 02, 2026 at 10:19 AM GMT+05:00

November 02, 2026 (MLN): Net loss of Liven Pharma Limited (PSX: LIVEN) narrowed 75.56% year-on-year to Rs7.37m for the quarter ended September 30, 2026, compared with Rs30.16m in the same period last year.

Basic and diluted loss per share (LPS) improved to Rs0.07 from a restated Rs0.28 in the corresponding quarter last year.

The narrower loss came from an 81.66% drop in other expenses, lower administrative and selling costs and a surge in other income, along with a larger taxation credit. A gross loss, against a gross profit last year, partly offset the gains.

Sales grew 62.04% to Rs14.29m from Rs8.82m. Cost of sales rose more than three-fold, up 244.93% to Rs16.87m from Rs4.89m, which pushed the company into a gross loss of Rs2.57m, against a gross profit of Rs3.93m last year.

Administrative and general expenses fell 26.11% to Rs7.06m from Rs9.56m, while selling and distribution expenses declined 27.05% to Rs3.48m from Rs4.77m. Other expenses dropped 81.66% to Rs3.80m from Rs20.72m. Finance costs edged down 5.82% to Rs0.60m from Rs0.63m.

As a result, the operating loss narrowed 44.85% to Rs17.51m from Rs31.75m.

Other income surged to Rs7.60m from Rs4,032 last year, which narrowed the loss before levies and taxation 68.79% to Rs9.91m from Rs31.74m.

Levies declined 4.55% to Rs0.18m from Rs0.19m, taking the loss before taxation down 68.41% to Rs10.09m from Rs31.93m.

A taxation credit of Rs2.71m, up 53.21% from Rs1.77m, cushioned the loss further and left it at Rs7.37m.

STATEMENT OF PROFIT OR LOSS FOR QUARTER ENDED SEPTEMBER 30, 2026 (Rupees)

Description

2026

2025

Change (%)

Sales

14,293,355

8,820,810

62.04%

Cost of sales

(16,865,196)

(4,889,428)

244.93%

Gross (loss) / profit

(2,571,841)

3,931,382

Administrative and general expenses

(7,060,596)

(9,555,737)

-26.11%

Selling and distribution expenses

(3,476,898)

(4,765,879)

-27.05%

Other expenses

(3,799,999)

(20,720,838)

-81.66%

Finance costs

(597,713)

(634,636)

-5.82%

Operating loss

(17,507,047)

(31,745,708)

-44.85%

Other income

7,600,294

4,032

Loss before levies and taxation

(9,906,753)

(31,741,676)

-68.79%

Levies

(178,667)

(187,184)

-4.55%

Loss before taxation

(10,085,420)

(31,928,860)

-68.41%

Taxation

2,713,880

1,771,388

53.21%

Loss after taxation

(7,371,540)

(30,157,472)

-75.56%

Loss per share - Basic and diluted (restated)

(0.07)

(0.28)

-75.00%

 

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 166,223.36
88.37M
-0.11%
-185.90
ALLSHR 100,414.30
194.54M
-0.29%
-293.48
KSE30 48,860.27
16.28M
-0.34%
-166.38
KMI30 237,524.23
20.86M
-0.19%
-447.51
KMIALLSHR 64,815.70
124.08M
-0.32%
-208.28
BKTi 45,574.29
4.54M
-0.81%
-369.94
OGTi 33,833.85
1.41M
0.55%
185.27
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 78,590.00 79,040.00
76,820.00
1620.00
2.10%
BRENT CRUDE 109.79 112.41
109.40
-3.64
-3.21%
RICHARDS BAY COAL MONTHLY 134.00 0.00
0.00
0.75
0.56%
ROTTERDAM COAL MONTHLY 148.05 0.00
0.00
0.30
0.20%
USD RBD PALM OLEIN 1,182.50 1,182.50
1,182.50
0.00
0.00%
CRUDE OIL - WTI 100.51 102.75
100.15
-3.61
-3.47%
SUGAR #11 WORLD 19.37 0.00
0.00
0.01
0.05%

Chart of the Day


Latest News
November 02, 2026 at 11:00 AM GMT+05:00

Supernet Technologies Q1 profit rises 5% to Rs131m


November 02, 2026 at 10:47 AM GMT+05:00

Practical reforms to stabilize LPG prices and supply


November 02, 2026 at 10:29 AM GMT+05:00

Qatar condemns attack on LNG carrier Al Mayeda in Arabian Gulf


November 02, 2026 at 10:19 AM GMT+05:00

Liven Pharma cuts quarterly loss by 76% to Rs7m


November 02, 2026 at 10:01 AM GMT+05:00

Citi Pharma 1QFY27 profit rises 22% to Rs249m



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg